Bristol-Myers Squibb Co (BMY)

57.58 +0.64  +1.13% NYSE Oct 19, 16:00 57.53 -0.06  -0.10% After-Hours: 20:00 USD

Bristol-Myers Squibb Cash from Investing (TTM):

-11.99B for June 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 1990. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 -11.99B
March 31, 2021 -11.61B
Dec. 31, 2020 -10.86B
Sept. 30, 2020 -10.91B
June 30, 2020 -10.52B
March 31, 2020 -10.36B
Dec. 31, 2019 -9.913B
Sept. 30, 2019 804.00M
June 30, 2019 166.00M
March 31, 2019 -897.00M
Dec. 31, 2018 -2.00B
Sept. 30, 2018 481.00M
June 30, 2018 770.00M
March 31, 2018 94.00M
Dec. 31, 2017 -66.00M
Sept. 30, 2017 -1.069B
June 30, 2017 -1.579B
March 31, 2017 -149.00M
Dec. 31, 2016 1.48B
Sept. 30, 2016 480.00M
June 30, 2016 786.00M
March 31, 2016 -900.00M
Dec. 31, 2015 -1.572B
Sept. 30, 2015 -237.00M
June 30, 2015 -11.00M
   
March 31, 2015 -242.00M
Dec. 31, 2014 1.216B
Sept. 30, 2014 550.00M
June 30, 2014 -89.00M
March 31, 2014 1.479B
Dec. 31, 2013 -572.00M
Sept. 30, 2013 20.00M
June 30, 2013 -3.708B
March 31, 2013 -3.539B
Dec. 31, 2012 -6.727B
Sept. 30, 2012 -6.509B
June 30, 2012 -2.469B
March 31, 2012 -3.027B
Dec. 31, 2011 -1.437B
Sept. 30, 2011 -4.411B
June 30, 2011 -3.30B
March 31, 2011 -2.73B
Dec. 31, 2010 -3.812B
Sept. 30, 2010 -2.36B
June 30, 2010 -5.297B
March 31, 2010 -5.973B
Dec. 31, 2009 -4.38B
Sept. 30, 2009 -2.279B
June 30, 2009 3.62B
March 31, 2009 3.577B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Benchmarks

Biogen Inc -436.20M
Gilead Sciences Inc -11.87B
Johnson & Johnson -13.33B

Cash from Investing (TTM) Range, Past 5 Years

Minimum -11.99B Jun 2021
Maximum 1.48B Dec 2016
Average -4.112B

News

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.